Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Genetics of the human placenta: implications for toxicokinetics.

Gundacker C, Neesen J, Straka E, Ellinger I, Dolznig H, Hengstschläger M.

Arch Toxicol. 2016 Nov;90(11):2563-2581. Epub 2016 Sep 6. Review.

PMID:
27600793
2.

Don't trust an(t)ybody - Pitfalls during investigation of candidate proteins for methylmercury transport at the placental interface.

Ellinger I, Chatuphonprasert W, Reiter M, Voss A, Kemper J, Straka E, Scheinast M, Zeisler H, Salzer H, Gundacker C.

Placenta. 2016 Jul;43:13-6. doi: 10.1016/j.placenta.2016.04.011. Epub 2016 Apr 20.

PMID:
27324094
3.

STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion.

Gotthardt D, Putz EM, Grundschober E, Prchal-Murphy M, Straka E, Kudweis P, Heller G, Bago-Horvath Z, Witalisz-Siepracka A, Cumaraswamy AA, Gunning PT, Strobl B, Müller M, Moriggl R, Stockmann C, Sexl V.

Cancer Discov. 2016 Apr;6(4):414-29. doi: 10.1158/2159-8290.CD-15-0732. Epub 2016 Feb 12.

4.

Mercury toxicokinetics of the healthy human term placenta involve amino acid transporters and ABC transporters.

Straka E, Ellinger I, Balthasar C, Scheinast M, Schatz J, Szattler T, Bleichert S, Saleh L, Knöfler M, Zeisler H, Hengstschläger M, Rosner M, Salzer H, Gundacker C.

Toxicology. 2016 Jan 18;340:34-42. doi: 10.1016/j.tox.2015.12.005. Epub 2015 Dec 29.

PMID:
26740192
5.

Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance.

Gotthardt D, Putz EM, Straka E, Kudweis P, Biaggio M, Poli V, Strobl B, Müller M, Sexl V.

Blood. 2014 Oct 9;124(15):2370-9. doi: 10.1182/blood-2014-03-564450. Epub 2014 Sep 2.

6.

CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance.

Putz EM, Gotthardt D, Hoermann G, Csiszar A, Wirth S, Berger A, Straka E, Rigler D, Wallner B, Jamieson AM, Pickl WF, Zebedin-Brandl EM, Müller M, Decker T, Sexl V.

Cell Rep. 2013 Aug 15;4(3):437-44. doi: 10.1016/j.celrep.2013.07.012. Epub 2013 Aug 8.

7.

Age-specific differences in binding of heparin to plasma proteins.

Ignjatovic V, Straka E, Summerhayes R, Monagle P.

J Thromb Haemost. 2010 Jun;8(6):1290-4. doi: 10.1111/j.1538-7836.2010.03847.x. Epub 2010 Mar 9.

8.

Population-specific variation in haplotype composition and heterozygosity at the POLB locus.

Yamtich J, Speed WC, Straka E, Kidd JR, Sweasy JB, Kidd KK.

DNA Repair (Amst). 2009 May 1;8(5):579-84. doi: 10.1016/j.dnarep.2008.12.005. Epub 2009 Jan 23.

9.

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.

Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R, Zelterman D, Kidd KK, Zhu Y, Christiani DC, Belinsky SA, Slack FJ, Weidhaas JB.

Cancer Res. 2008 Oct 15;68(20):8535-40. doi: 10.1158/0008-5472.CAN-08-2129.

10.

Social work early intervention for young children with developmental disabilities.

Malone DM, McKinsey PD, Thyer BA, Straka E.

Health Soc Work. 2000 Aug;25(3):169-80. Review.

PMID:
10948456
11.
12.

31P-NMR spectroscopy of human cancer cells proliferating in a basement membrane gel.

Daly PF, Lyon RC, Straka EJ, Cohen JS.

FASEB J. 1988 Jul;2(10):2596-604.

PMID:
3384239
13.

Clarification requests of normal and language-impaired children.

Hargrove PM, Straka EM, Medders EG.

Br J Disord Commun. 1988 Apr;23(1):51-61. No abstract available.

PMID:
3245933
14.
15.

A high intensity ultraviolet light monochromator.

Sayre RM, Straka ER, Anglin JH Jr, Everett MA.

J Invest Dermatol. 1965 Sep;45(3):190-3. No abstract available.

Supplemental Content

Loading ...
Support Center